1. Home
  2. NKGN vs STKH Comparison

NKGN vs STKH Comparison

Compare NKGN & STKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKGN
  • STKH
  • Stock Information
  • Founded
  • NKGN 2017
  • STKH 2018
  • Country
  • NKGN United States
  • STKH Israel
  • Employees
  • NKGN N/A
  • STKH N/A
  • Industry
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • STKH Packaged Foods
  • Sector
  • NKGN Health Care
  • STKH Consumer Staples
  • Exchange
  • NKGN Nasdaq
  • STKH Nasdaq
  • Market Cap
  • NKGN 9.5M
  • STKH 8.1M
  • IPO Year
  • NKGN N/A
  • STKH 2021
  • Fundamental
  • Price
  • NKGN $0.33
  • STKH $2.39
  • Analyst Decision
  • NKGN
  • STKH
  • Analyst Count
  • NKGN 0
  • STKH 0
  • Target Price
  • NKGN N/A
  • STKH N/A
  • AVG Volume (30 Days)
  • NKGN 900.0K
  • STKH 16.1K
  • Earning Date
  • NKGN 11-26-2024
  • STKH 08-30-2024
  • Dividend Yield
  • NKGN N/A
  • STKH N/A
  • EPS Growth
  • NKGN N/A
  • STKH N/A
  • EPS
  • NKGN N/A
  • STKH N/A
  • Revenue
  • NKGN N/A
  • STKH N/A
  • Revenue This Year
  • NKGN N/A
  • STKH N/A
  • Revenue Next Year
  • NKGN N/A
  • STKH N/A
  • P/E Ratio
  • NKGN N/A
  • STKH N/A
  • Revenue Growth
  • NKGN N/A
  • STKH N/A
  • 52 Week Low
  • NKGN $0.20
  • STKH $2.19
  • 52 Week High
  • NKGN $4.06
  • STKH $7.70
  • Technical
  • Relative Strength Index (RSI)
  • NKGN 52.26
  • STKH 34.52
  • Support Level
  • NKGN $0.26
  • STKH $2.19
  • Resistance Level
  • NKGN $0.33
  • STKH $2.80
  • Average True Range (ATR)
  • NKGN 0.04
  • STKH 0.16
  • MACD
  • NKGN 0.01
  • STKH -0.02
  • Stochastic Oscillator
  • NKGN 50.97
  • STKH 27.87

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is a deep-tech food company. The company is cultivating meat technologies to improve meat production, simplify the meat supply chain, and offer consumers a range of new product offerings. The company aims to provide an alternative to industrialized animal farming that reduces carbon footprint, minimizes water and land usage, and prevents the slaughtering of animals. It is developing a novel, proprietary three-dimensional bioprinter for three-dimensional printing of meat and seafood analogs, followed by hybrid meats that combine cultivated and plant-based elements.

Share on Social Networks: